» Articles » PMID: 35980580

Studying Protein Function Using Nanobodies and Other Protein Binders in Drosophila

Overview
Specialty Molecular Biology
Date 2022 Aug 18
PMID 35980580
Authors
Affiliations
Soon will be listed here.
Abstract

The direct manipulation of proteins by nanobodies and other protein binders has become an additional and valuable approach to investigate development and homeostasis in Drosophila. In contrast to other techniques, that indirectly interfere with proteins via their nucleic acids (CRISPR, RNAi, etc.), protein binders permit direct and acute protein manipulation. Since the first use of a nanobody in Drosophila a decade ago, many different applications exploiting protein binders have been introduced. Most of these applications use nanobodies against GFP to regulate GFP fusion proteins. In order to exert specific protein manipulations, protein binders are linked to domains that confer them precise biochemical functions. Here, we reflect on the use of tools based on protein binders in Drosophila. We describe their key features and provide an overview of the available reagents. Finally, we briefly explore the future avenues that protein binders might open up and thus further contribute to better understand development and homeostasis of multicellular organisms.

Citing Articles

Enhancement of SARS-CoV-2 receptor-binding domain activity by two microbial defensins.

Gao B, Zhu S Front Microbiol. 2023; 14:1195156.

PMID: 37405160 PMC: 10315472. DOI: 10.3389/fmicb.2023.1195156.


Construction of an alpaca immune antibody library for the selection of nanobodies against proteins.

Qiu J, Li J, Zhang Z, Dong S, Ling X, Fang Z Front Bioeng Biotechnol. 2023; 11:1207048.

PMID: 37362207 PMC: 10289234. DOI: 10.3389/fbioe.2023.1207048.


Engineered kinases as a tool for phosphorylation of selected targets in vivo.

Lepeta K, Roubinet C, Bauer M, Vigano M, Aguilar G, Kanca O J Cell Biol. 2022; 221(10).

PMID: 36102907 PMC: 9477969. DOI: 10.1083/jcb.202106179.

References
1.
Caussinus E, Kanca O, Affolter M . Fluorescent fusion protein knockout mediated by anti-GFP nanobody. Nat Struct Mol Biol. 2011; 19(1):117-21. DOI: 10.1038/nsmb.2180. View

2.
Toyama B, Hetzer M . Protein homeostasis: live long, won't prosper. Nat Rev Mol Cell Biol. 2012; 14(1):55-61. PMC: 3570024. DOI: 10.1038/nrm3496. View

3.
Pluckthun A . Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy. Annu Rev Pharmacol Toxicol. 2015; 55:489-511. DOI: 10.1146/annurev-pharmtox-010611-134654. View

4.
Helma J, Cardoso M, Muyldermans S, Leonhardt H . Nanobodies and recombinant binders in cell biology. J Cell Biol. 2015; 209(5):633-44. PMC: 4460151. DOI: 10.1083/jcb.201409074. View

5.
Beghein E, Gettemans J . Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein-Protein Interaction Analysis, and Protein Function Exploration. Front Immunol. 2017; 8:771. PMC: 5495861. DOI: 10.3389/fimmu.2017.00771. View